It has long been observed that the ERα and/or PgR status of the metastatic tissue may be discordant with that of the primary tumour [235–237], with ERα+ but PgR− breast tumours comprising the poorer-prognosis Luminal B subtype. This evidence concerns the gene ESR1 and breast neoplasm.